Basiliximab
Basiliximab
Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 gamma1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer
Stoffgruppe
Immunsuppressivum (Interleukin-Inhibitor)
Halbwertszeit
7,2 ± 3,2 Tage